4-Hydroperoxy Cyclophosphamide from Santa Cruz Biotechnology, Inc.

Product Specs
Item4-Hydroperoxy Cyclophosphamide
CompanySanta Cruz Biotechnology, Inc.
Price $375.00Supplier Page View Company Product Page
Catalog Numbersc-206885
Quantity5 mg
TypeBiochemical Reagents
Molecular Weight293.08

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Lymphodepleting chemotherapy potentiates neoantigen-directed T cell therapy by enhancing antigen presentationCell reports. MedicineDecember 16, 2025Sagie S, Babu T, Weller C, Tabachnik C, Livneh I, Quast NP, Gumpert N, Shomuradova A, Raybould MI, Levy R, et al.,Fisher Scientific,Cat#07-201-431 Bovine Serum Albumin,Sigma Aldrich,A8577-50M 4-Hydroperoxy Cyclophosphamide,Santa Cruz,SC-206885 Fludarabine,ApexBio,A5424 Human Serum,MALE AB HUMAN SERUM HI,Beit Haemek- AC-001-1B-HI Epoxomicin,Sigma

(2) Cyclophosphamide, hydroxycyclophosphamide and carboxyethyl phosphoramide mustard quantification with liquid chromatography mass spectrometry in a single run human plasma samples: A rapid and sensitive method developmentJournal of chromatography. B, Analytical technologies in the biomedical and life sciencesMay 15, 2022Shanker Kasudhan K, Patial A, Mehra N, Verma Attri S, Malhotra P, Pattanaik S, Lad D, Patil AN.

(3) Cyclophosphamide Induces the Ferroptosis of Tumor Cells Through Heme Oxygenase-1Frontiers in pharmacologyJanuary 1, 2022Shi H, Hou B, Li H, Zhou H, Du B.

(4) Estrogen inhibits the growth of colon cancer in mice through reversing extracellular vesicle-mediated immunosuppressive tumor microenvironmentCancer lettersNovember 1, 2021Jiang L, Fei H, Yang A, Zhu J, Sun J, Liu X, Xu W, Yang J, Zhang S.

(5) Apoptotic and Non-Apoptotic Modalities of Thymoquinone-Induced Lymphoma Cell Death: Highlight of the Role of Cytosolic Calcium and NecroptosisCancersJuly 16, 2021Berehab M, Rouas R, Akl H, Duvillier H, Journe F, Fayyad-Kazan H, Ghanem G, Bron D, Lewalle P, Merimi M.

(6) Ligustrazine alleviates cyclophosphamide-induced hepatotoxicity via the inhibition of Txnip/Trx/NF-κB pathwayLife sciencesJune 1, 2021Ma X, Ruan Q, Ji X, Yang J, Peng H.

(7) Use of the cell division assay to diagnose Fanconi anemia patients'' hypersensitivity to mitomycin CCytometry. Part B, Clinical cytometryMay 1, 2021Hammarsten O, Muslimovic A, Thunström S, Ek T, Johansson P.

(8) Exploiting Protein Translation Dependence in Multiple Myeloma with Omacetaxine-Based TherapyClinical cancer research : an official journal of the American Association for Cancer ResearchFebruary 1, 2021Walker ZJ, Idler BM, Davis LN, Stevens BM, VanWyngarden MJ, Ohlstrom D, Bearrows SC, Hammes A, Smith CA, Jordan CT, et al.

(9) Occupational Safety in Chemosensitivity Tests: A Method to Minimize the Risk of Contamination While Maximizing the Safety for the ExaminerChemotherapyJanuary 1, 2021Henrich M, Hartung S, Herden C.

(10) Lingering effects of chemotherapy on mature T cells impair proliferationBlood advancesOctober 13, 2020Das RK, O''Connor RS, Grupp SA, Barrett DM.

(11) Measurement of ex vivo resistance to proteasome inhibitors, IMiDs, and daratumumab during multiple myeloma progressionBlood advancesApril 28, 2020Walker ZJ, VanWyngarden MJ, Stevens BM, Abbott D, Hammes A, Langouët-Astrie C, Smith CA, Palmer BE, Forsberg PA, Mark TM, et al.

(12) Medium dose intermittent cyclophosphamide induces immunogenic cell death and cancer cell autonomous type I interferon production in glioma modelsCancer lettersFebruary 1, 2020Du B, Waxman DJ.

(13) Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug TreatmentFrontiers in oncologyJanuary 1, 2020Sharick JT, Walsh CM, Sprackling CM, Pasch CA, Pham DL, Esbona K, Choudhary A, Garcia-Valera R, Burkard ME, McGregor SM, et al.

(14) PI3K/AKT inhibition reverses R-CHOP resistance by destabilizing SOX2 in diffuse large B cell lymphomaTheranosticsJanuary 1, 2020Chen J, Ge X, Zhang W, Ding P, Du Y, Wang Q, Li L, Fang L, Sun Y, Zhang P, et al.

(15) Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapyNature communicationsAugust 27, 2019Kim JY, Ohn J, Yoon JS, Kang BM, Park M, Kim S, Lee W, Hwang S, Kim JI, Kim KH, et al.for HSCT. Busulfan (50 μmol/L; B2635, Sigma Aldrich) and 4-hydroperoxycyclophosphamide (40 μmol/L; sc-206885, Santa Cruz Biotechnology, Santa Cruz, CA, USA) were added to Williams’ E medium for HF organ culture

(16) Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamideThe Journal of endocrinologyFebruary 1, 2019Luan Y, Edmonds ME, Woodruff TK, Kim SY.Bioscientifica.com at 11/16/2021 08:02:40AM via free access Journal of Endocrinology Y Luan et al. 4-HC (sc-206885, Santa Cruz Biotechnology, Inc., Dallas, TX), dissolved in DMSO (D2650, MilliporeSigma), was added to

(17) A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasisOncogeneAugust 1, 2018Pavan S, Meyer-Schaller N, Diepenbruck M, Kalathur RKR, Saxena M, Christofori G.

(18) Role of metabolites of cyclophosphamide in cardiotoxicityBMC research notesAugust 14, 2017Kurauchi K, Nishikawa T, Miyahara E, Okamoto Y, Kawano Y.metaphosphoric acid (MPA: Cat. #239275) were purchased from SIGMA-Aldrich (St. Louis, MO), HCY (Cat. #sc-206885) and CEPM (Cat. #sc-207411) were purchased from Santa Cruz Biotechnology (Dallas, TX). Acrolein (Cat.

(19) Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B-cell acute lymphoblastic leukaemiaBritish journal of haematologyAugust 1, 2016Randhawa S, Cho BS, Ghosh D, Sivina M, Koehrer S, Müschen M, Peled A, Davis RE, Konopleva M, Burger JA.

(20) BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma modelsOncotargetJuly 12, 2016Ambati SR, Shieh JH, Pera B, Lopes EC, Chaudhry A, Wong EW, Saxena A, Su TL, Moore MA.

Be the First to Write a Review!

4-Hydroperoxy Cyclophosphamide Chemicals

4-Hydroperoxy Cyclophosphamide from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (24)

Reviews

4-Hydroperoxy Cyclophosphamide from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map